Related Experiment Video
Updated: Apr 26, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Safety of statins: an update
Miao Hu1, Bernard M Y Cheung2, Brian Tomlinson1
1Division of Clinical Pharmacology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
Statins effectively prevent cardiovascular events by lowering LDL cholesterol. While generally safe, rare muscle and liver issues can occur, but benefits outweigh risks for most patients.
Area of Science:
- Cardiology
- Pharmacology
- Hepatology
Background:
- Statins are primary agents for atherosclerotic vascular disease prevention.
- They effectively reduce low-density lipoprotein (LDL) cholesterol.
- While generally safe, potential adverse effects include muscle and liver issues.
Purpose of the Study:
- To review the safety and efficacy of statin therapy.
- To evaluate risks versus benefits, particularly in patients with liver abnormalities.
- To inform clinical practice regarding statin use.
Main Methods:
- Review of existing clinical trial data and observational studies.
- Analysis of adverse event profiles associated with statin use.
- Assessment of cardiovascular outcomes and liver function markers.
Main Results:
- Statins significantly reduce atherosclerotic events.
- Muscle toxicity (myopathy, rhabdomyolysis) is rare at standard doses.
- Asymptomatic liver enzyme elevations do not predict liver disease; statins may improve liver tests in NAFLD patients.
Conclusions:
- Statin therapy is safe and beneficial for cardiovascular disease prevention.
- Cardiovascular benefits generally outweigh risks, including those of new-onset diabetes and hemorrhagic stroke.
- Statins can be safely used in patients with mild-to-moderate liver abnormalities, including those with NAFLD.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Cholesterol: Significance and Regulation
Considering cholesterol and...
Coronary Artery Disease V: Interprofessional Care

